Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc operates in various business sectors.
Osmotica Pharmaceuticals plc (O1P) - Total Assets
Latest total assets as of June 2023: €85.40 Million EUR
Based on the latest financial reports, Osmotica Pharmaceuticals plc (O1P) holds total assets worth €85.40 Million EUR as of June 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Osmotica Pharmaceuticals plc - Total Assets Trend (2018–2022)
This chart illustrates how Osmotica Pharmaceuticals plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Osmotica Pharmaceuticals plc - Asset Composition Analysis
Current Asset Composition (December 2022)
Osmotica Pharmaceuticals plc's total assets of €85.40 Million consist of 44.3% current assets and 55.7% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 34.7% |
| Accounts Receivable | €947.00K | 0.7% |
| Inventory | €784.00K | 0.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €13.90 Million | 10.8% |
| Goodwill | €55.85 Million | 43.5% |
Asset Composition Trend (2018–2022)
This chart illustrates how Osmotica Pharmaceuticals plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Osmotica Pharmaceuticals plc's current assets represent 44.3% of total assets in 2022, an increase from 21.7% in 2018.
- Cash Position: Cash and equivalents constituted 34.7% of total assets in 2022, up from 8.9% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 53.0% of total assets, a decrease from 73.0% in 2018.
- Asset Diversification: The largest asset category is goodwill at 43.5% of total assets.
Osmotica Pharmaceuticals plc Competitors by Total Assets
Key competitors of Osmotica Pharmaceuticals plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
Osmotica Pharmaceuticals plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Osmotica Pharmaceuticals plc generates 0.39x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Osmotica Pharmaceuticals plc is currently not profitable relative to its asset base.
Osmotica Pharmaceuticals plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.38 | 2.17 | 0.43 |
| Quick Ratio | 0.36 | 2.14 | 0.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-42.64 Million | € 21.63 Million | € -30.55 Million |
Osmotica Pharmaceuticals plc - Advanced Valuation Insights
This section examines the relationship between Osmotica Pharmaceuticals plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -11.2% |
| Total Assets | €128.51 Million |
| Market Capitalization | $40.36 USD |
Valuation Analysis
Below Book Valuation: The market values Osmotica Pharmaceuticals plc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Osmotica Pharmaceuticals plc's assets decreased by 11.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Osmotica Pharmaceuticals plc (2018–2022)
The table below shows the annual total assets of Osmotica Pharmaceuticals plc from 2018 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | €128.51 Million | -11.17% |
| 2021-12-31 | €144.67 Million | -61.00% |
| 2020-12-31 | €370.95 Million | -19.93% |
| 2019-12-31 | €463.25 Million | -41.78% |
| 2018-12-31 | €795.64 Million | -- |